Measuring the global burden of disease and epidemiological transitions: 2002–2030

Abstract Any planning process for health development ought to be based on a thorough understanding of the health needs of the population. This should be sufficiently comprehensive to include the causes of premature death and of disability, as well as the major risk factors that underlie disease and injury. To be truly useful to inform health-policy debates, such an assessment is needed across a large number of diseases, injuries and risk factors, in order to guide prioritization. The results of the original Global Burden of Disease Study and, particularly, those of its 2000–2002 update provide a conceptual and methodological framework to quantify and compare the health of populations using a summary measure of both mortality and disability: the disability-adjusted life-year (DALY). Globally, it appears that about 56 million deaths occur each year, 10.5 million (almost all in poor countries) in children. Of the child deaths, about one-fifth result from perinatal causes such as birth asphyxia and birth trauma, and only slightly less from lower respiratory infections. Annually, diarrhoeal diseases kill over 1.5 million children, and malaria, measles and HIV/AIDS each claim between 500,000 and 800,000 children. HIV/AIDS is the fourth leading cause of death world-wide (2.9 million deaths) and the leading cause in Africa. The top three causes of death globally are ischaemic heart disease (7.2 million deaths), stroke (5.5 million) and lower respiratory diseases (3.9 million). Chronic obstructive lung diseases (COPD) cause almost as many deaths as HIV/AIDS (2.7 million). The leading causes of DALY, on the other hand, include causes that are common at young ages [perinatal conditions (7.1% of global DALY), lower respiratory infections (6.7%), and diarrhoeal diseases (4.7%)] as well as depression (4.1%). Ischaemic heart disease and stroke rank sixth and seventh, retrospectively, as causes of global disease burden, followed by road traffic accidents, malaria and tuberculosis. Projections to 2030 indicate that, although these major vascular diseases will remain leading causes of global disease burden, with HIV/AIDS the leading cause, diarrhoeal diseases and lower respiratory infections will be outranked by COPD, in part reflecting the projected increases in death and disability from tobacco use.

[1]  A Sawai,et al.  [Changes in life expectancy]. , 1973, Kangogaku zasshi.

[2]  E. Markell,et al.  Intestinal nematode infections. , 1985, Pediatric clinics of North America.

[3]  C. Cheung,et al.  Atlas of the global distribution of schistosomiasis. , 1987 .

[4]  D. Jamison,et al.  Disease Control Priorities in Developing Countries , 1993 .

[5]  L. Gallagher Hepatitis B. , 2016, Journal.

[6]  BOMBAY CALCUrIA,et al.  World development report 1993--investing in health. , 1993, Communicable disease report. CDR weekly.

[7]  Dean T. Jamison,et al.  World development report 1993 : investing in health , 1993 .

[8]  Alan D. Lopez,et al.  Evidence-Based Health Policy--Lessons from the Global Burden of Disease Study , 1996, Science.

[9]  J. Bryant,et al.  Disease Control Priorities in Developing Countries , 1996 .

[10]  Alan D. Lopez,et al.  The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .

[11]  Alan D. Lopez,et al.  Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study , 1997, The Lancet.

[12]  Alan D. Lopez,et al.  Mortality by cause for eight regions of the world: Global Burden of Disease Study , 1997, The Lancet.

[13]  M S Chan,et al.  The global burden of intestinal nematode infections--fifty years on. , 1997, Parasitology today.

[14]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.

[15]  P. Piot,et al.  Global prevalence and incidence estimates of selected curable STDs. , 1998, Sexually transmitted infections.

[16]  V. Mathan Diarrhoeal diseases. , 1998, British medical bulletin.

[17]  Duane J. Gubler,et al.  Dengue and Dengue Hemorrhagic Fever , 1998, Clinical Microbiology Reviews.

[18]  F. Rodríguez Artalejo,et al.  [Towards evidence-based public health?]. , 1999, Medicina clinica.

[19]  F. RodríguezArtalejo,et al.  [Towards evidence-based public health?]. , 1999 .

[20]  R. Snow,et al.  Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. , 1999, Bulletin of the World Health Organization.

[21]  S. Brooker,et al.  Towards an atlas of human helminth infection in sub-Saharan Africa: the use of geographical information systems (GIS). , 2000, Parasitology today.

[22]  GLOBAL PREVALENCE AND INCIDENCE OF SELECTED CURABLE SEXUALLY TRANSMITTED DISEASES: OVERVIEW AND ESTIMATES , 2000 .

[23]  Leprosy--global situation. , 2000, Releve epidemiologique hebdomadaire.

[24]  J. Habbema,et al.  Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination , 2001, BMC public health.

[25]  D. Wasserman,et al.  Changes in life expectancy in Russia , 2001, The Lancet.

[26]  F. Richards,et al.  Control of onchocerciasis today: status and challenges. , 2001, Trends in parasitology.

[27]  M. Mckee,et al.  Changes in life expectancy in Russia in the mid-1990s , 2001, The Lancet.

[28]  Joshua A. Salomon,et al.  World mortality in 2000: life tables for 191 countries. , 2002 .

[29]  Majid Ezzati,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[30]  Joshua A. Salomon,et al.  The Epidemiologic Transition Revisited: Compositional Models for Causes of Death by Age and Sex , 2002 .

[31]  Michael Beasley,et al.  Use of remote sensing and a geographical information system in a national helminth control programme in Chad. , 2002, Bulletin of the World Health Organization.

[32]  C. Dye,et al.  Estimates of world-wide distribution of child deaths from acute respiratory infections. , 2002, The Lancet. Infectious diseases.

[33]  P Duclos,et al.  How best to estimate the global burden of pertussis? , 2003, The Lancet. Infectious diseases.

[34]  Jan J Barendregt,et al.  A generic model for the assessment of disease epidemiology: the computational basis of DisMod II , 2003, Population health metrics.

[35]  Tim Brown,et al.  Methods and procedures for estimating HIV/AIDS and its impact: the UNAIDS/WHO estimates for the end of 2001 , 2003, AIDS.

[36]  Dirk Engels,et al.  Soil-transmitted helminth infections: updating the global picture. , 2003, Trends in parasitology.

[37]  Estimating the burden and economic impact of trachomatous visual loss , 2003, Ophthalmic epidemiology.

[38]  Christopher Dye,et al.  The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. , 2003, Archives of internal medicine.

[39]  Mary Ellen Kitler,et al.  Global burden of disease (GBD) for hepatitis C , 2004 .

[40]  C. Boschi-Pinto,et al.  Methods and assumptions for diarrhoea mortality estimates. , 2004 .

[41]  Alan D. Lopez,et al.  Comparative quantification of health risks. Global and regional burden of disease attributable to selected major risk factors. Volume 1. , 2004 .

[42]  M. Thod Global Burden of Disease (GBD) for Hepatitis C , 2004, Journal of clinical pharmacology.

[43]  Igor Rudan,et al.  Global estimate of the incidence of clinical pneumonia among children under five years of age. , 2004, Bulletin of the World Health Organization.

[44]  G. Medley,et al.  Intestinal nematode infections , 2004 .

[45]  D. Lavanchy,et al.  Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures , 2004, Journal of viral hepatitis.

[46]  M. Ranson,et al.  The global burden of trachomatous visual impairment: I. Assessing prevalence , 1995, International Ophthalmology.

[47]  J. Salomon,et al.  Integrating HIV Prevention and Treatment: From Slogans to Impact , 2005, PLoS medicine.

[48]  C. Mathers,et al.  Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.

[49]  Alan D. Lopez,et al.  The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001 -- Global Burden of Disease and Risk Factors , 2006 .

[50]  Alan D. Lopez,et al.  Demographic and Epidemiological Characteristics of Major Regions, 1990–2001 , 2006 .

[51]  J. Lawson Comparative Quantification of Health Risks. Global and Regional Burden of Disease Attributable to Selected Major Risk Factors , 2006 .